» Articles » PMID: 35602841

Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury

Overview
Journal Cureus
Date 2022 May 23
PMID 35602841
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.

Citing Articles

Diagnostic Challenges in a Case of Immune-Mediated Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency.

Escoto-Pineda K, Alas-Pineda C, Pavon-Varela D, Cortes D Cureus. 2024; 16(8):e67138.

PMID: 39185293 PMC: 11345097. DOI: 10.7759/cureus.67138.

References
1.
Phillips E, Westwood J, Brocklebank V, Wong E, Tellez J, Marchbank K . The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies. J Thromb Haemost. 2015; 14(1):175-85. PMC: 4737436. DOI: 10.1111/jth.13189. View

2.
Raife T, Atkinson B, Montgomery R, Vesely S, Friedman K . Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion. 2004; 44(2):146-50. DOI: 10.1111/j.1537-2995.2004.00626.x. View

3.
Little D, Mathias L, Page E, Kremer Hovinga J, Vesely S, George J . Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura. Kidney Int Rep. 2017; 2(6):1088-1095. PMC: 5733749. DOI: 10.1016/j.ekir.2017.06.007. View

4.
Brocklebank V, Wood K, Kavanagh D . Thrombotic Microangiopathy and the Kidney. Clin J Am Soc Nephrol. 2017; 13(2):300-317. PMC: 5967417. DOI: 10.2215/CJN.00620117. View

5.
George J, Nester C . Syndromes of thrombotic microangiopathy. N Engl J Med. 2014; 371(7):654-66. DOI: 10.1056/NEJMra1312353. View